DOCTORS'
Medical Case Studies
DOCTORS'
Medical Case Studies
Sorafenib
Renal cell carcinoma
Renal cell carcinoma (RCC, also known as hypernephroma) is a kidney cancer that originates in the lining of the proximal convoluted tubule, the very small tubes in the kidney that filter the blood and remove waste products. RCC is the most common type of kidney cancer in adults, responsible for approximately 80% of cases. It is also known to be the most lethal of all the genitourinary tumors. Initial treatment is most commonly a radical or partial nephrectomy and remains the mainstay of curative treatment. Where the tumour is confined to the renal parenchyma, the 5-year survival rate is 60-70%, but this is lowered considerably where metastases have spread...
Sorafenib - List of case studies
- Drugs
-
drops Solumedrol Somatostatin analogue Sorafenib Sotalol Spasmolytics Spasmomen Statin therapy ...
- Portosystemic Encephalopathy in Hepatocellular Carcinoma
-
has very limited efficacy for these patients. Sorafenib has modest benefit compared to best supportive care. It is not ... the patients Childs Pugh score or CLIP score . Sorafenib is primary indicated in Childs A and some B patients. However, I ... canrenoate, furosemide, omeprazole, folina, rifaximin, sorafenib (Case Studies) ...
- Papillary Carcinoma of Thyroid with Multiple and Diffuse Nodular Secondarisms of the Pulmonary Parenchyma
-
responsive to radioiodine treatment, such as vandetanib, sorafenib, motesanib, sunitinib, abitins or similar? Do you think it is already ... , such as AMG 706 (Sherman, NEJM, 2008) and sorafenib (Gupta, JCO, 2008). At present, there is no one targeted therapy ...